title: Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
authors.forename: Pasquale
authors.initials: P
authors.lastname: Niscola
authors.forename: Roberto
authors.initials: R
authors.lastname: Palumbo
authors.forename: Laura
authors.initials: L
authors.lastname: Scaramucci
authors.forename: Andrea
authors.initials: A
authors.lastname: Tendas
authors.forename: Luca
authors.initials: L
authors.lastname: Cupelli
authors.forename: Marco
authors.initials: M
authors.lastname: Giovannini
authors.forename: Daniela
authors.initials: D
authors.lastname: Piccioni
authors.forename: Teresa
authors.initials: T
authors.lastname: Dentamaro
authors.forename: Alessio Pio
authors.initials: AP
authors.lastname: Perrotti
authors.forename: Paolo
authors.initials: P
authors.lastname: de Fabritiis
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy*; D006435:Renal Dialysis; D000069283:Rituximab; D013160:Splenic Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab